Abstract
The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Current Signal Transduction Therapy
Title:Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Volume: 8 Issue: 3
Author(s): Damian Matak, Lukasz Szymanski, Anna Czarnecka, Ewa Bartnik and Cezary Szczylik
Affiliation:
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Abstract: The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Export Options
About this article
Cite this article as:
Matak Damian, Szymanski Lukasz, Czarnecka Anna, Bartnik Ewa and Szczylik Cezary, Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics, Current Signal Transduction Therapy 2013; 8 (3) . https://dx.doi.org/10.2174/1574362409666140206222607
DOI https://dx.doi.org/10.2174/1574362409666140206222607 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study
Current Medicinal Chemistry Advances of Bioinformatics Applied to Development and Evaluation of Boron-Containing Compounds
Current Organic Chemistry Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective
Anti-Cancer Agents in Medicinal Chemistry 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry Structure, Function and Biological Relevance of Prolyl Oligopeptidase
Current Protein & Peptide Science mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Clinical Considerations of Focal Drug Delivery in Cancer Treatment
Current Drug Delivery Production of Retroviral Vectors: Review
Current Gene Therapy The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
Current Drug Targets Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Current Drug Targets - Inflammation & Allergy Recent Applications of Artificial Intelligence in Early Cancer Detection
Current Medicinal Chemistry The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design Recent Research Progress on Magnetic Nanocomposites with Silica Shell Structures Preparation and Nanotheranostic Applications
Recent Patents on Nanotechnology Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Current Cancer Drug Targets Small Molecule Regulators Targeting NAD<sup>+ </sup>Biosynthetic Enzymes
Current Medicinal Chemistry Medicinal and Cosmetic Potentials of Sophorolipids
Mini-Reviews in Medicinal Chemistry Overview on Anticancer Drug Design and Development
Current Medicinal Chemistry